Related Experiment Videos
Endothelin-1 and 5-fluorouracil-induced cardiotoxicity
1Department of Internal Medicine and Medical Therapy, University of Pavia, Italy.
Neoplasma
|August 4, 1998
Summary
5-Fluorouracil (5-FU) chemotherapy can cause cardiotoxicity, potentially mediated by endothelin-1 (ET-1). This study observed high ET-1 levels in patients with 5-FU-induced heart failure and angina, suggesting ET-1
Area of Science:
- Cardiology
- Oncology
- Pharmacology
Background:
- 5-Fluorouracil (5-FU) is a widely used chemotherapy agent.
- Cardiotoxicity is a rare but serious adverse effect of 5-FU chemotherapy.
- Coronary artery vasospasm is a suspected mechanism in 5-FU-induced cardiotoxicity.
Observation:
- Two patients receiving 5-FU chemotherapy presented with angina pectoris and chronic heart failure.
- Elevated plasma levels of endothelin-1 (ET-1), a potent vasoconstrictor, were detected in these patients.
Findings:
- The study proposes endothelin-1 (ET-1) as a potential mediator of 5-FU-induced cardiotoxicity.
- High ET-1 levels correlate with clinical manifestations of cardiac toxicity, including angina and heart failure.
Implications:
- Understanding the role of ET-1 may lead to novel therapeutic strategies for preventing or treating 5-FU cardiotoxicity.
- Further research is needed to elucidate the precise mechanism of ET-1 elevation and its causal relationship with 5-FU cardiotoxicity.